Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
absorption, accrual, Africa, appraiser, assembly, beneficiary, call, compounded, Cruz, deconsolidated, disagreement, Drug, East, economy, exercisable, exercise, exercised, goal, immaterial, Middle, month, passed, permanent, Santa, social, SSAR, strike, subcontract, test, transparency, transportation
Removed:
ESG, FDA
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view